On Wednesday, BioMérieux is set to open its $125 million Molecular and Genomic Innovation Center at the Navy Yard in South Philadelphia, tripling its footprint in the city. The French biotechnology company entered Philadelphia in 2019 with its $75 million acquisition of Invisible Sentinel. The 32,000-square-foot center is located in the newly developed 1201 Normandy Place, a six-story building developed by Ensemble Real Estate Investments, Mosaic Development Partners, and Oxford Properties. Miguel Villa, BioMérieux’s senior VP of industrial microbiology, said the Navy Yard was chosen for its growth potential and proximity to clients.

*Article courtesy of Philadelphia Business Journal

For more information about Philadelphia medical space for sale or lease or about any other properties for sale or lease, please contact WCRE at 215-799-6900.

Wolf Commercial Real Estate, a full-service CORFAC International brokerage and advisory firm, is a premier  medical commercial real estate broker that provides a full range of commercial real estate listings and services, property management services, and marketing commercial offices, medical, industrial and land, retail buildings and other commercial properties for buyers, tenants, investors, and sellers.

Please visit our website for a full listing of Philadelphia commercial properties for sale or lease, www.wolfcre.com.